Codexis, Inc.

NASDAQ:CDXS

2.44 (USD) • At close June 30, 2025
Bedrijfsnaam Codexis, Inc.
Symbool CDXS
Munteenheid USD
Prijs 2.44
Beurswaarde 202,141,312
Dividendpercentage 0%
52-weken bereik 1.9 - 6.08
Industrie Biotechnology
Sector Healthcare
CEO Dr. Stephen George Dilly MBBS, Ph.D.
Website https://www.codexis.com

An error occurred while fetching data.

Over Codexis, Inc.

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In

Vergelijkbare Aandelen

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

25.84 USD

Evolus, Inc. logo

Evolus, Inc.

EOLS

9.21 USD

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

RCKT

2.45 USD

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

2.05 USD

Merus N.V. logo

Merus N.V.

MRUS

52.6 USD

Verve Therapeutics, Inc. logo

Verve Therapeutics, Inc.

VERV

11.23 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

6.52 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)